Malaria is a parasitic infectious disease that infects humans and other animals. As technology continues to advance, scientists are finding that glycobiology plays a major role in the in-depth study of malaria, because most of the interactions are mediated by the carbohydrate or glycan portion that decorates the surface of the parasite and the host cell. CD BioGlyco provides the most comprehensive malaria glycomics analysis services with our professional glycobiology experts. Our researchers have proven experience in Glycoinformatics-assisted Glycomics Analysis, especially Disease Glycomics Analysis.
In malaria parasites, CD BioGlyco provides high-quality glycan abundance analysis including N-glycans, O-glycans, C-glycans, and glycosylphosphatidylinositols (GPIs).
Although the presence of N-glycans, O-glycans, and C-glycans in malaria parasites is very limited, our researchers provide accurate analysis and visualization of data evaluation services.
Relying on our reliable staff, CD BioGlyco provides N-glycan and N-glycosylation site identification services to elucidate the functional mechanism of proteins. Moreover, we provide C-mannosylation, α-galactosylation O-glycosylation analyses such as O-fucosylation and O-glcNAcylation analysis.
Our researchers construct special molecular models based on molecular biology information provided by our clients. Our computational staff provides binding site prediction and identification services, binding free energy calculation and optimization services, ligand structure design services, key structure fragment prediction and characterization services, and data statistics and presentation services.
Technology: SPR analysis, Molecular modeling, Molecular docking, Immunofluorescence microscopy, In vitro growth inhibition assay (GIA)
Journal: Cell Reports
Published: 2024
IF: 7.5
Results: In this work, researchers identified a novel targeted glycan lectin, P. falciparum cysteine-rich protective antigen (PfCyRPA), which includes 2-6-linked N-acetylneuraminic acid (Neu5Ac) at its terminus. The researchers predicted the PfCyRPA binding site by molecular modeling and mutagenesis-assisted validation. After a series of analyses, it was shown that modification of PfCyRPA lectin activity through targeting is a potential pathway for the development of malaria therapeutics.
Fig.1 Molecular model of PfCyRPA in complex. (Day, et al., 2024)
By utilizing advanced computational methods, CD BioGlyco provides our clients with easy access to malaria glycomics analysis. We combine the analytical strengths of different disciplines to provide the most satisfying solutions for our clients. Please feel free to contact us.
Reference
We envision a future where the intricate world of carbohydrate is no longer shrouded in mystery, but rather illuminated by the power of cutting-edge computational tools.